Abstract
OBJECTIVE: The authors' aim was to determine survival and recurrence rates in patients undergoing resection of rectal cancer achieved by abdominoperineal resection (APR), coloanal anastomosis (CAA), and anterior resection (AR) without adjuvant therapy. SUMMARY BACKGROUND DATA: The surgery of rectal cancer is controversial; so, too, is its adjuvant management. Questions such as preoperative versus postoperative radiation versus no radiation are key. An approach in which the entire mesorectum is excised has been proposed as yielding low recurrence rates. METHODS: Of 1423 patients with resected rectal cancers, 491 patients were excluded, leaving 932 with a primary adenocarcinoma of the rectum treated at Mayo. Eighty-six percent were resected for cure. Surgery plus adjuvant treatment was performed in 418, surgery alone in 514. These 514 patients are the subject of this review. Among the 514 patients who underwent surgery alone, APR was performed in 169, CAA in 19, AR in 272, and other procedures in 54. Eighty-seven percent of patients were operated on with curative intent. The mean follow-up was 5.6 years; follow-up was complete in 92%. APR and CAA were performed excising the envelope of rectal mesentery posteriorly and the supporting tissues laterally from the sacral promontory to the pelvic floor. AR was performed using an appropriately wide rectal mesentery resection technique if the tumor was high; if the tumor was in the middle or low rectum, all mesentery was resected. The mean distal margin achieved by AR was 3 +/- 2 cm. RESULTS: Mortality was 2% (12 of 514). Anastomotic leaks after AR occurred in 5% (16 of 291) and overall transient urinary retention in 15%. Eleven percent of patients had a wound infection (abdominal and perineal wound, 30-day, purulence, or cellulitis). The local recurrence and 5-year disease-free survival rates were 7% and 78%, respectively, after AR; 6% and 83%, respectively, after CAA; and 4% and 80%, respectively, after APR. Patients with stage III disease, had a 60% disease-free survival rate. CONCLUSIONS: Complete resection of the envelope of supporting tissues about the rectum during APR, CAA, and AR when tumors were low in the rectum is associated with low mortality, low morbidity, low local recurrence, and good 5-year survival rates. Appropriate "tumor-specific" mesorectal excision during AR when the tumor is high in the rectum is likewise consistent with a low rate of local recurrence and good long-term survival. However, the overall failure rate of 40% in stage III disease (which is independent of surgical technique) means that surgical approaches alone are not sufficient to achieve better long-term survival rates.
Full text
PDF









Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carmona J. A., Ortiz H., Perez-Cabañas I. Alterations in anorectal function after anterior resection for cancer of the rectum. Int J Colorectal Dis. 1991 May;6(2):108–110. doi: 10.1007/BF00300205. [DOI] [PubMed] [Google Scholar]
- Enker W. E., Thaler H. T., Cranor M. L., Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995 Oct;181(4):335–346. [PubMed] [Google Scholar]
- Fisher B., Wolmark N., Rockette H., Redmond C., Deutsch M., Wickerham D. L., Fisher E. R., Caplan R., Jones J., Lerner H. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst. 1988 Mar 2;80(1):21–29. doi: 10.1093/jnci/80.1.21. [DOI] [PubMed] [Google Scholar]
- GRINNELL R. S. Distal intramural spread of carcinoma of the rectum and rectosigmoid. Surg Gynecol Obstet. 1954 Oct;99(4):421–430. [PubMed] [Google Scholar]
- Heald R. J., Ryall R. D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986 Jun 28;1(8496):1479–1482. doi: 10.1016/s0140-6736(86)91510-2. [DOI] [PubMed] [Google Scholar]
- Holm T., Johansson H., Cedermark B., Ekelund G., Rutqvist L. E. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg. 1997 May;84(5):657–663. [PubMed] [Google Scholar]
- Karanjia N. D., Schache D. J., Heald R. J. Function of the distal rectum after low anterior resection for carcinoma. Br J Surg. 1992 Feb;79(2):114–116. doi: 10.1002/bjs.1800790206. [DOI] [PubMed] [Google Scholar]
- Karanjia N. D., Schache D. J., North W. R., Heald R. J. 'Close shave' in anterior resection. Br J Surg. 1990 May;77(5):510–512. doi: 10.1002/bjs.1800770512. [DOI] [PubMed] [Google Scholar]
- Kollmorgen C. F., Meagher A. P., Wolff B. G., Pemberton J. H., Martenson J. A., Illstrup D. M. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg. 1994 Nov;220(5):676–682. doi: 10.1097/00000658-199411000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krook J. E., Moertel C. G., Gunderson L. L., Wieand H. S., Collins R. T., Beart R. W., Kubista T. P., Poon M. A., Meyers W. C., Mailliard J. A. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991 Mar 14;324(11):709–715. doi: 10.1056/NEJM199103143241101. [DOI] [PubMed] [Google Scholar]
- Kusunoki M., Shoji Y., Yanagi H., Kamikonya N., Sakanoue Y., Hishikawa Y., Utsunomiya J. Anorectal function after preoperative intraluminal brachytherapy and colonic J pouch-anal anastomosis for rectal carcinoma. Br J Surg. 1993 Jul;80(7):933–935. doi: 10.1002/bjs.1800800749. [DOI] [PubMed] [Google Scholar]
- Lewis W. G., Holdsworth P. J., Stephenson B. M., Finan P. J., Johnston D. Role of the rectum in the physiological and clinical results of coloanal and colorectal anastomosis after anterior resection for rectal carcinoma. Br J Surg. 1992 Oct;79(10):1082–1086. doi: 10.1002/bjs.1800791032. [DOI] [PubMed] [Google Scholar]
- MacFarlane J. K., Ryall R. D., Heald R. J. Mesorectal excision for rectal cancer. Lancet. 1993 Feb 20;341(8843):457–460. doi: 10.1016/0140-6736(93)90207-w. [DOI] [PubMed] [Google Scholar]
- McCall J. L., Cox M. R., Wattchow D. A. Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis. 1995;10(3):126–132. doi: 10.1007/BF00298532. [DOI] [PubMed] [Google Scholar]
- QUER E. A., DAHLIN D. C., MAYO C. W. Retrograde intramural spread of carcinoma of the rectum and rectosigmoid; a microscopic study. Surg Gynecol Obstet. 1953 Jan;96(1):24–30. [PubMed] [Google Scholar]
- Sagar P. M., Pemberton J. H. Surgical management of locally recurrent rectal cancer. Br J Surg. 1996 Mar;83(3):293–304. doi: 10.1002/bjs.1800830305. [DOI] [PubMed] [Google Scholar]
- Scott N., Jackson P., al-Jaberi T., Dixon M. F., Quirke P., Finan P. J. Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg. 1995 Aug;82(8):1031–1033. doi: 10.1002/bjs.1800820808. [DOI] [PubMed] [Google Scholar]
- Tveit K. M., Guldvog I., Hagen S., Trondsen E., Harbitz T., Nygaard K., Nilsen J. B., Wist E., Hannisdal E. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg. 1997 Aug;84(8):1130–1135. [PubMed] [Google Scholar]
- Willett C. G., Tepper J. E., Kaufman D. S., Shellito P. C., Eliseo R., Convery K., Wood W. C. Adjuvant postoperative radiation therapy for rectal adenocarcinoma. Am J Clin Oncol. 1992 Oct;15(5):371–375. doi: 10.1097/00000421-199210000-00001. [DOI] [PubMed] [Google Scholar]
- Wilson S. M., Beahrs O. H. The curative treatment of carcinoma of the sigmoid, rectosigmoid, and rectum. Ann Surg. 1976 May;183(5):556–565. doi: 10.1097/00000658-197605000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
